NEU neuren pharmaceuticals limited

NEU Vs Reata, page-43

  1. 34,438 Posts.
    lightbulb Created with Sketch. 9327
    My apologies for saying limit of 10% daily volume.
    Yesterday's buyback volume is way higher than I expected.
    The high buyback means the board believes current share price is undervalued.

    Current cash position is around $210m, royalties payment plus bank interest are around $18m, which is about to cover current expenditure. However the expenditure should increase as PMS proceeds to the Phase 3 trial next year, imo. NEU is to receive additional US$100m next quarter, so cash position will be well above $300m. I won't be surprised if the share buyback is upsized at next AGM in May 2025.

    All imo.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$13.31
Change
0.770(6.14%)
Mkt cap ! $1.655B
Open High Low Value Volume
$12.96 $14.00 $12.91 $19.76M 1.453M

Buyers (Bids)

No. Vol. Price($)
1 3000 $13.30
 

Sellers (Offers)

Price($) Vol. No.
$13.33 3716 1
View Market Depth
Last trade - 16.10pm 26/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.